Companies › NRSN

NEUROSENSE THERAPEUTICS LTD (NRSN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001875091 · EDGAR filings · Updated 2026-07-22

NEUROSENSE THERAPEUTICS LTD (NRSN) has reported institutional ownership of 1.2%, with 13 institutional managers holding positions valued at $286.7K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-22 — Foreign issuer report (6-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-29 — Foreign issuer report (6-K) filed
• 2026-06-25 — Foreign issuer report (6-K) filed
• 2026-06-17 — Insider transaction reported (Form 4)
• 2026-06-17 — Insider transaction reported (Form 4)
• 2026-06-11 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NEUROSENSE THERAPEUTICS LTD has 13 institutional holders and institutional ownership of 1.2%.

Insider activity

Insiders reported 2 transactions (0 buys, 0 sells) across 9 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

MANGOCEUTICALS INC (MGRX) · KALA BIO Inc (KALA) · FIBROBIOLOGICS INC (FBLG) · Tenon Medical Inc (TNON) · TransCode Therapeutics Inc (RNAZ) · ENSYSCE BIOSCIENCES INC (ENSC)